Site icon OncologyTube

GRACE Targeted Therapies Lung Cancer 2021 – Single Agent Immunotherapy If Driver Mutation Positive?

The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.

For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty.

In this video, from the PM session of the event, Drs. Ben Levy, Jack West and Zosia Piotrowska discuss if there is ever a role for single-agent immunotherapy in driver mutation-positive patients.

A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Exit mobile version